Search results

Found 5,185 pages
AUTHOR: Kevin Grogan

Results per page

10 20 50 100

Sort by

Relevance Date

26 Jan 2015:

USA fast-tracks Shire Hunter syndrome drug

Shire’s good run is continuing with the news that the US Food and Drug Administration has granted fast-track designation for SHP609 (idursulfase-IT) for the treatment of neurocognitive decline associated with Hunter syndrome. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/usa_fast-tracks_shire_hunter_syndrome_drug_970931

1 Oct 2010:

GSK pulls Simplirix herpes vaccine

GlaxoSmithKline has decided not to pursue further worldwide development of Simplirix, an experimental vaccine intended to prevent genital herpes disease in women.  - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/gsk_pulls_simplirix_herpes_vaccine_982325

5 Jan 2015:

B-MS inks fibrosis pact with Calibr

Bristol-Myers Squibb has linked up with the California Institute for Biomedical Research to develop anti-fibrotic therapies. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/b-ms_inks_fibrosis_pact_with_calibr_970805

18 Mar 2011:

Sanofi signs biomarker pact with Epistem

Sanofi-Aventis has entered into a cancer collaboration with the Manchester, UK-based stem cell specialist Epistem. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/sanofi_signs_biomarker_pact_with_epistem_979410

16 Nov 2012:

FDA panel mixed on Dynavax hepatitis vaccine

Advisors to the US Food and Drug Administration have backed the efficacy of Dynavax' hepatitis B vaccine Heplisav but expressed concerns about its safety profile. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/fda_panel_mixed_on_dynavax_hepatitis_vaccine_976217

4 Feb 2015:

Amgen biosimilar matches Humira in RA trial

Amgen’s biosimilar of Humira has shown comparable efficacy for moderate-to-severe rheumatoid arthritis in a late-stage trial with AbbVie’s branded inflammatory blockbuster - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/amgen_biosimilar_matches_humira_in_ra_trial_970984

10 Jan 2014:

Shire extends offer for ViroPharma again

Shire has extended its tender offer to buy ViroPharma for a second time, now expiring on midnight January 23. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/shire_extends_offer_for_viropharma_again_1001342

8 Jan 2015:

Roche signs Parkinson's pact with 23andMe

Roche’s Genentech unit has linked up with personal genetics company 23andMe to identify new therapeutic targets for Parkinson’s disease. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/roche_signs_parkinsons_pact_with_23andme_970837

8 Jan 2014:

Nestle pact with stem cell biotech CDI

Food giant Nestle has linked up with USA-based stem cell specialist Cellular Dynamics International. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/nestle_pact_with_stem_cell_biotech_cdi_1001327

6 Oct 2010:

Watson takes stake in Brazil's Moksha8

Watson Pharmaceuticals is looking to expand its presence in Latin America by linking up with Brazil's Moksha8. - News - PharmaTimes

by Kevin Grogan

https://www.pharmatimes.com/news/watson_takes_stake_in_brazils_moksha8_982304